Best Practices for the Implementation of Clinical Advances in HR-Positive/HER2-Negative Breast Cancer

In this online program with content from a live symposium experts discuss recent advances in the management of HR-positive/HER2-negative breast cancer. Watch the on-demand webcast from the live event download the symposium slides and read expert commentary on current clinical questions in this setting.

Share

Program Content

Activities

HR+/HER2- Breast Cancer
Best Practices for the Implementation of Clinical Advances in HR-Positive/HER2-Negative Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2022

Expires: March 29, 2023

Activities

Advances in HR+/HER2- BC
Recent Advances in Oral Therapies for HR+/HER2- Breast Cancer: A Pharmacy Perspective
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2022

Expires: April 24, 2023

Activities

Advances in HR+/HER2- Breast Cancer
Best Practices for the Implementation of Clinical Advances in HR-Positive/HER2-Negative Breast Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2022

Expires: May 02, 2023

Faculty

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
Assistant Adjunct Professor
UK College of Pharmacy
Lexington, Kentucky

cover img faculity

Kristina F. Byers, PharmD, BCOP

Clinical Pharmacy Specialist
Breast Oncology
Emory Winship Cancer Institute
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Lilly